Does guanfacine interact with any of the following medications: levocetirizine, albuterol (Ventolin), hydrochlorothiazide, inclisiran, fluticasone‑salmeterol, fluticasone‑umeclidinium‑vilanterol, ergocalciferol (vitamin D2), escitalopram, pantoprazole, montelukast, clonidine, methocarbamol, and losartan?

Guanfacine Drug Interactions with Your Medication List

Yes, guanfacine has clinically significant interactions with several medications on this list, most importantly with clonidine (additive hypotensive and sedative effects), levocetirizine and methocarbamol (additive CNS depression), and escitalopram (additive sedation). The combination with clonidine requires particular caution as both are central alpha-2 agonists.

Critical Interactions Requiring Monitoring

Clonidine (Most Significant)

• Both guanfacine and clonidine are central alpha-2 adrenergic agonists that can cause additive hypotension, bradycardia, and sedation 1
• The European Society of Cardiology specifically warns that central acting antihypertensives like clonidine and guanfacine "may precipitate or exacerbate depression, bradycardia, and orthostatic hypotension" 2
• Monitor blood pressure closely and watch for excessive sedation, dizziness, or falls 1
• Both medications carry rebound hypertension risk if discontinued abruptly, requiring careful tapering 1

CNS Depressants (Levocetirizine, Methocarbamol, Escitalopram)

• Guanfacine causes dose-related sedation and drowsiness, with additive effects when combined with other CNS depressants 1
• The FDA label explicitly states: "When guanfacine hydrochloride is used with other centrally active depressants, the potential for additive sedative effects should be considered" 1
• Levocetirizine (antihistamine): Expect enhanced sedation and drowsiness
• Methocarbamol (muscle relaxant): Additive CNS depression and sedation
• Escitalopram (SSRI): While SSRIs can cause sedation, the interaction is generally mild but monitor for increased drowsiness 1

Antihypertensive Medications (Hydrochlorothiazide, Losartan)

• Guanfacine was studied with diuretics without reported drug interactions 1
• However, additive blood pressure lowering effects are expected when combining multiple antihypertensives
• Monitor blood pressure regularly to avoid excessive hypotension 1
• The combination is commonly used but requires dose adjustment based on blood pressure response

No Clinically Significant Interactions

Respiratory Medications

• Albuterol (Ventolin), fluticasone-salmeterol, and fluticasone-umeclidinium-vilanterol have no documented interactions with guanfacine 1
• The FDA label specifically notes that guanfacine was given concomitantly with bronchodilators (13 patients) in long-term safety studies without evidence of interactions 1

Other Medications

• Inclisiran (lipid-lowering): No interaction expected; different mechanism and metabolism
• Ergocalciferol (vitamin D): No interaction
• Pantoprazole (PPI): No interaction documented 1
• Montelukast (leukotriene inhibitor): No documented interaction

Important Clinical Considerations

Monitoring Requirements

• Blood pressure and heart rate monitoring is essential, especially during initiation and dose adjustments 1
• Watch for orthostatic hypotension, particularly in combination with clonidine and other antihypertensives 2, 1
• Assess for excessive sedation that may impair driving or operating machinery 1

Abrupt Discontinuation Warning

• Never stop guanfacine abruptly - taper gradually to avoid rebound hypertension, nervousness, and anxiety 1
• This is particularly critical when also taking clonidine, as both carry rebound risk 2, 1

Enzyme Interactions (Not Applicable Here)

• Guanfacine is metabolized by CYP3A4; strong inhibitors or inducers would require dose adjustment 3
• None of the medications on this list are significant CYP3A4 inhibitors or inducers

Bottom Line

The primary concern is the combination of guanfacine with clonidine (both central alpha-2 agonists), which requires close blood pressure monitoring and assessment for excessive sedation or bradycardia 2, 1. Secondary concerns include additive CNS depression with levocetirizine, methocarbamol, and escitalopram 1. The remaining medications have no clinically significant interactions with guanfacine.